Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Dec 2, 2014
    Ads for Ebola ‘Treatments’ Elicit Rare Joint Warning Letters from FDA and FTC
  • Nov 21, 2014
    Justice Dept.: False Claims Act Recoveries Drop $300 Million to $2.3 Billion in Fiscal 2014
  • Nov 20, 2014
    OPDP Seeks OMB's OK for Major Study on Consumer Understanding of Risk-Reward Information in DTC Ads
  • Nov 14, 2014
    FDA Looks To Study Spousal Influence on Decision Making After Viewing DTC Ads
  • Nov 12, 2014
    Pfizer Settles Last of the Neurontin Class Action Suits for $325 Million
  • Nov 11, 2014
    FDA Plans To Study Link Between Memory and Repeated Viewing in DTC Commercials
  • Nov 6, 2014
    Untitled Letter Hammers Firm Over Risk Information, Superiority Claims in Sales Aid
  • Nov 3, 2014
    FDA Draft Guidance on Social Media Promotion Met With Concern, Anger
  • Oct 31, 2014
    FTC Complaint Accuses Gerber of False Advertising With Allergy Protection Claims
  • Oct 28, 2014
    Group Accused of Promoting Supplement as Ebola Cure Requests Enforcement Discretion
  • More

Good Clinical Practice

  • Jun 3, 2016
    FDA Provides Guidance on Expanded Access
  • Jun 2, 2016
    Insurance Coverage Is Key Risk Management Concern in Clinical Trials
  • Jun 2, 2016
    SCRS and Black Cardiologists Aim To Increase Clinical Investigator Diversity
  • May 31, 2016
    Draft Guidance Outlines FDA Categorization of IDE Devices for Medicare Coverage Decisions
  • May 26, 2016
    Britain Leaving EU Could Hurt Its Clinical Trials
  • May 25, 2016
    France Issues Recommendations on Phase 1 Trials
  • May 24, 2016
    Subjects Should Get Their Individual Results from Research: SACHRP
  • May 24, 2016
    Group Sets Up Platform To Share Patient-level Data
  • May 24, 2016
    BioMed Central, Crossref Develop Way To Tie Clinical Trials and All Publications
  • May 24, 2016
    Survey Finds One-third of Respondents ‘Likely’ To Enroll in Clinical Trial
  • More

FDA Regulation & Enforcement

  • Feb 13, 2019
    Consent Decree Shutters Another Compounding Pharmacy Due to Insanitary Conditions at Facility
  • Feb 13, 2019
    Washington Senate Bill Calls for 2 Percent Tax on Drug Advertising Revenues
  • Feb 13, 2019
    Changes Are Coming in DTC TV Advertising
  • Feb 12, 2019
    N.Y. Assembly Considers Bill Requiring Drug Makers To Report Gifts To Healthcare Practitioners
  • Feb 10, 2019
    J&J Will Add Pricing Info to DTC TV Ads
  • Feb 8, 2019
    Michigan Bill Calls for Cost Reporting
  • Feb 7, 2019
    Infusion Drug Compounder Settles False Claims Allegations for $17 Million, Enters Into Five-Year CIA
  • Feb 7, 2019
    House Members Want FDA To Take Action on ‘Dairy’ Labeling
  • Feb 6, 2019
    Delaware Court Allows State Opioid Marketing Lawsuit to Continue
  • Feb 5, 2019
    Bill Requiring Reporting of Marketing Costs for Expensive Drugs Introduced in Minnesota
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.